{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:01:16Z","timestamp":1777496476048,"version":"3.51.4"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The primary psychoactive compound in cannabis, \u22069-tetrahydrocannabinol (THC) induces intoxication and functional impairment, raising safety concerns in driving. The traditional impairment detection method, behavioral field sobriety tests (FSTs), are subject to bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether resting-state functional near-infrared spectroscopy (fNIRS) can detect THC-related impairment with greater accuracy and a lower rate of false positives than FSTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This double-blind, randomized, crossover trial was conducted from January 2017 to January 2021 at a single site. Eligible participants were adults aged 18 to 55 years who used cannabis. Analyses were performed from November 2024 to November 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Participants received a single oral dose of synthetic THC (range, 5-80 mg) intended to induce intoxication or placebo in separate visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome and Measures<\/jats:title>\n                    <jats:p>fNIRS scans were acquired before and approximately 100 and 200 minutes after study drug administration to assess prefrontal cortex responses at rest and during a working memory task. Machine learning models trained on fNIRS data were then used to identify clinically determined THC-induced impairment. The primary outcome of this study was accuracy of THC-induced impairment classification using fNIRS data as compared with an FST. Model performance was quantified using false-positive rate, precision, recall, F1 score, and area under the receiver operating curve (ROC-AUC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 183 participants (mean [SD] age, 25.3 [6.3] years; 90 [49.2%] female) who used cannabis for a median (IQR) of 6.5 (4-7) days per week completed at least 1 study visit. fNIRS data collected during rest produced a classifier for impairment, with an ROC-AUC of 0.87 (95% CI, 0.83 to 0.91), accuracy of 0.90 (95% CI, 0.88 to 0.92), and false-positive rate of 0.05 (95% CI, 0.04 to 0.07), using clinical impairment assessment as ground truth. The FST showed an ROC-AUC of 0.75 (95% CI, 0.74 to 0.76), accuracy of 0.69 (95% CI, 0.67 to 0.71), and a false-positive rate of 0.34 (95% CI, 0.32 to 0.36). fNIRS performed significantly better than the FST in precision (difference\u2009=\u20090.23; 95% CI, 0.14 to 0.33;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), accuracy (difference\u2009=\u20090.15; 95% CI, 0.10 to 0.19;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), false-positive rate (difference\u2009=\u2009\u22120.25, 95% CI, \u22120.31 to \u22120.20;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and ROC-AUC (difference\u2009=\u20090.08; 95% CI, 0.01 to 0.14;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this crossover trial of THC vs placebo, THC intoxication produced prefrontal cortex activation patterns detectable with resting state fNIRS neuroimaging, producing a neural signature of THC-induced impairment that was superior to FSTs for individual-level impairment identification. These findings lay the groundwork for further exploration of fNIRS as a tool for detecting impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT03655717\">NCT03655717<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.56647","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:30:18Z","timestamp":1769790618000},"page":"e2556647","source":"Crossref","is-referenced-by-count":1,"title":["Detection of \u03949-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy"],"prefix":"10.1001","volume":"9","author":[{"given":"Moshe","family":"Berchansky","sequence":"first","affiliation":[{"name":"Faculty of Engineering, Institute of Nanotechnology and Advanced Materials, The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Eden","family":"Evins","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryn","family":"Evohr","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary","family":"Himmelsbach","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys N.","family":"Pachas","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerthana Deepti","family":"Karunakaran","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"MGH\/HST Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bracha","family":"Laufer Goldshtein","sequence":"additional","affiliation":[{"name":"School of Computer and Electrical Engineering, Tel-Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisan","family":"Ozana","sequence":"additional","affiliation":[{"name":"Faculty of Engineering, Institute of Nanotechnology and Advanced Materials, The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi M.","family":"Gilman","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"MGH\/HST Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"2","key":"zoi251503r2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMsa2109371","article-title":"Cannabis legalization and detection of tetrahydrocannabinol in injured drivers.","volume":"386","author":"Brubacher","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi251503r3","doi-asserted-by":"publisher","first-page":"e256379","DOI":"10.1001\/jamanetworkopen.2025.6379","article-title":"Prevalence of impairing substance use in injured drivers.","volume":"8","author":"Brubacher","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi251503r4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamapsychiatry.2023.2309","article-title":"High traffic\u2014the quest for a reliable test of cannabis impairment.","volume":"80","author":"Ramaekers","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"zoi251503r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.11.004","article-title":"Are blood and oral fluid ?9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis.","volume":"134","author":"McCartney","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"zoi251503r6","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1360-0443.2012.03928.x","article-title":"Medicinal ?(9)-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.","volume":"107","author":"Bosker","year":"2012","journal-title":"Addiction"},{"issue":"11","key":"zoi251503r7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s40263-023-01046-z","article-title":"A semi-naturalistic, open-label trial examining the effect of prescribed medical cannabis on neurocognitive performance.","volume":"37","author":"Arkell","year":"2023","journal-title":"CNS Drugs"},{"issue":"5","key":"zoi251503r8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00007691-199810000-00021","article-title":"Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.","volume":"20","author":"Huestis","year":"1998","journal-title":"Ther Drug Monit"},{"issue":"9","key":"zoi251503r10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jamapsychiatry.2023.2345","article-title":"Evaluation of field sobriety tests for identifying drivers under the influence of cannabis: a randomized clinical trial.","volume":"80","author":"Marcotte","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"zoi251503r11","doi-asserted-by":"publisher","DOI":"10.4172\/2325-9841.1000120","article-title":"Standardized field sobriety test: false positive test rate among sober subjects.","author":"Yoshizuka","year":"2014","journal-title":"J Forensic Toxicol Pharmacol"},{"issue":"10","key":"zoi251503r12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1373\/clinchem.2015.245001","article-title":"Cannabis-impaired driving: a public health and safety concern.","volume":"61","author":"Huestis","year":"2015","journal-title":"Clin Chem"},{"issue":"1","key":"zoi251503r13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/cercor\/bhj136","article-title":"Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis.","volume":"17","author":"Eggan","year":"2007","journal-title":"Cereb Cortex"},{"issue":"7629","key":"zoi251503r14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of ?9-tetrahydrocannabinol on the dopamine system.","volume":"539","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"issue":"2","key":"zoi251503r15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.euroneuro.2018.12.003","article-title":"Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity.","volume":"29","author":"Mason","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"zoi251503r16","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1038\/s41598-022-06509-9","article-title":"Functional brain connectomes reflect acute and chronic cannabis use.","volume":"12","author":"Ramaekers","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"zoi251503r17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11682-015-9488-z","article-title":"Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.","volume":"10","author":"Ramaekers","year":"2016","journal-title":"Brain Imaging Behav"},{"key":"zoi251503r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106669","article-title":"Cannabis users demonstrate enhanced neural reactivity to reward: an event-related potential and time-frequency EEG study.","volume":"113","author":"Crane","year":"2021","journal-title":"Addict Behav"},{"issue":"4","key":"zoi251503r19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00213-011-2428-8","article-title":"Involvement of the endocannabinoid system in reward processing in the human brain.","volume":"219","author":"van Hell","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"zoi251503r20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41386-021-01259-0","article-title":"Identification of ?9-tetrahydrocannabinol (THC) impairment using functional brain imaging.","volume":"47","author":"Gilman","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"zoi251503r21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.neuroimage.2019.05.012","article-title":"Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: a report of a potential biomarker of intoxication.","volume":"197","author":"Gilman","year":"2019","journal-title":"Neuroimage"},{"issue":"9","key":"zoi251503r22","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41386-024-01876-5","article-title":"Intoxication due to ?9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity.","volume":"49","author":"Karunakaran","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"zoi251503r23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","article-title":"The drug effects questionnaire: psychometric support across three drug types.","volume":"227","author":"Morean","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"zoi251503r24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0013-4694(87)90206-9","article-title":"Cerebral location of international 10-20 system electrode placement.","volume":"66","author":"Homan","year":"1987","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"12","key":"zoi251503r25","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1118\/1.597496","article-title":"Spatial and temporal analysis of human motor activity using noninvasive NIR topography.","volume":"22","author":"Maki","year":"1995","journal-title":"Med Phys"},{"issue":"6","key":"zoi251503r27","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1007\/s10618-024-01062-7","article-title":"Detach-rocket: sequential feature selection for time series classification with random convolutional kernels.","volume":"38","author":"Uribarri","year":"2024","journal-title":"Data Min Knowl Discov"},{"issue":"1","key":"zoi251503r28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00213-007-0940-7","article-title":"Brain imaging study of the acute effects of ?9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana.","volume":"196","author":"Weinstein","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"zoi251503r29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053127","article-title":"Psychomotor function in chronic daily Cannabis smokers during sustained abstinence.","volume":"8","author":"Bosker","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"zoi251503r30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review.","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"18","key":"zoi251503r31","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.2174\/138161210791293097","article-title":"Dopaminergic modulation of cognitive control: distinct roles for the prefrontal cortex and the basal ganglia.","volume":"16","author":"van Schouwenburg","year":"2010","journal-title":"Curr Pharm Des"},{"key":"zoi251503r32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.puhe.2019.03.006","article-title":"Are oral fluid testing devices effective for the roadside detection of recent cannabis use? A systematic review.","volume":"171","author":"Dobri","year":"2019","journal-title":"Public Health"},{"key":"zoi251503r33","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.932119","article-title":"Functional time domain diffuse correlation spectroscopy.","volume":"16","author":"Ozana","year":"2022","journal-title":"Front Neurosci"},{"issue":"3","key":"zoi251503r34","doi-asserted-by":"publisher","DOI":"10.1117\/1.NPh.8.3.035006","article-title":"Superconducting nanowire single-photon sensing of cerebral blood flow.","volume":"8","author":"Ozana","year":"2021","journal-title":"Neurophotonics"},{"key":"zoi251503r26","author":"Ekambaram"},{"key":"zoi251503r1","unstructured":"Compton? R. Marijuana-Impaired driving: a report to Congress. National Highway Traffic Safety Administration. Published June 2017. Accessed December 17, 2025. https:\/\/www.nhtsa.gov\/sites\/nhtsa.gov\/files\/2023-05\/Appropriation-Marijuana-Report-to-Congress-2017-tag.pdf"},{"key":"zoi251503r9","unstructured":"National Highway Traffic Safety Administration. Advanced roadside impaired driving enforcement (ARIDE) R5\/13 edition participant manual. Published 2020. Accessed December 17, 2023. https:\/\/www.cji.edu\/wp-content\/uploads\/2019\/04\/2013_aride_participant_manual_r5-13_ed.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844566\/berchansky_2026_oi_251503_1769180911.12137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T16:30:20Z","timestamp":1769790620000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844566"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.56647","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}